Learn About Alveolar Soft Part Sarcoma

What is the definition of Alveolar Soft Part Sarcoma?
Alveolar soft part sarcoma (ASPS) is a rare, slow-growing soft tissue sarcoma. Although it has been described in a variety of locations, it most commonly develops on the lower extremities in adults and in the head and neck region of children. ASPS generally presents as a soft, pain-less lump that is often not associated with any additional signs and symptoms. In many cases, the condition is not diagnosed until the affected person develops symptoms of metastasis to other sites such as the lungs, bones, central nervous system and/or liver. The underlying cause of ASPS is poorly understood. Most cases occur sporadically in people with no family history of the condition.
Save information for later
Sign Up
What are the alternative names for Alveolar Soft Part Sarcoma?
  • Alveolar soft part sarcoma
  • ASPS
Who are the top Alveolar Soft Part Sarcoma Local Doctors?
NS
Dr. Neeta Somaiah
Oncology | Hematology Oncology
Elite
Highly rated in
31
conditions
Oncology
Hematology Oncology

University of Texas System

Physicians Referral Service

1515 Holcombe Blvd 
Houston, TX 77030

Neeta Somaiah is an Oncologist and a Hematologist Oncology doctor in Houston, Texas. Dr. Somaiah has been practicing medicine for over 21 years and is rated as an Elite doctor by MediFind in the treatment of Alveolar Soft Part Sarcoma. She is also highly rated in 31 other conditions, according to our data. Her top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, and Synovial Sarcoma. She is licensed to treat patients in Pennsylvania and Texas. Dr. Somaiah is currently accepting new patients.

View Profile
SS
Silvia Stacchiotti
Silvia Stacchiotti
Elite
Highly rated in
28
conditions

Fondazione IRCCS Istituto Nazionale Dei Tumori

Pediatric Oncology Unit 
Milan, IT 

Silvia Stacchiotti is in Milan, Italy. Stacchiotti is rated as an Elite expert by MediFind in the treatment of Alveolar Soft Part Sarcoma. She is also highly rated in 28 other conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Chondrosarcoma, and Solitary Fibrous Tumor.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
AC
Dr. Anthony P. Conley
Oncology
Elite
Highly rated in
30
conditions
Oncology

University of Texas System

Physicians Referral Service

1515 Holcombe Blvd 
Houston, TX 77030

Anthony Conley is an Oncologist in Houston, Texas. Dr. Conley has been practicing medicine for over 18 years and is rated as an Elite doctor by MediFind in the treatment of Alveolar Soft Part Sarcoma. He is also highly rated in 30 other conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Alveolar Soft Part Sarcoma, Synovial Sarcoma, and Liposarcoma. He is licensed to treat patients in Texas. Dr. Conley is currently accepting new patients.

View Profile
View All Doctors
What are the latest Alveolar Soft Part Sarcoma Clinical Trials?
An Open-label, Single-arm, Phase II Clinical Study of Anti-PD-1 Antibody GB226 in Treatment of Relapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma (ASPS)
Who is this study for: Adult patients with Metastatic or Unresectable Alveolar Soft Part Sarcoma
Status: Recruiting
Start Date: September 6, 2018
Intervention Type: Biological
Phase: Phase 2
View Trial
Summary: This study is a single-arm, phase 2 trial of Geptanolimab in patients with initially unresectable, recurrent or metastatic ASPS. The study aims to study the activity of Geptanolimab assessed per RECIST 1.1 and iRECIST criteria, and safety profile.
Match to trials
Find the right clinical trials for you in under a minute
Get started
Vessels Encapsulating Tumor Clusters (VETC), Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Gland Carcinoma
Status: Recruiting
Start Date: January 2, 2021
Intervention Type: Other
Study Drugs: Pazopanib, Sorafenib, Sunitinib
View Trial
Summary: Metastasis is the main cause of death in cancer patients and often epithelial-to-mesenchymal transition (EMT) is advocated as the basic mechanism. Recently Fang and colleagues described an EMT-independent process of metastasis in hepatocellular carcinoma (HCC): endothelium covers small cluster of tumor cells allowing tumor dissemination. This process of angiogenesis, named VETC (vessels that encap...
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Alveolar Soft Part Sarcoma?
Clinical observation of local intervention combined with camrelizumab and apatinib in the treatment of metastatic soft-tissue sarcoma.
Condition: Metastatic Soft-Tissue Sarcoma (mSTS)
Journal: Journal of cancer research and therapeutics
Treatment Used: Local Intervention Combined with Camrelizumab and Apatinib
Number of Patients: 33
Published: April 06, 2022
View publication
Summary: Clinical observation of local intervention combined with camrelizumab and apatinib in the treatment of metastatic soft-tissue sarcoma.
A PRIMARY BLADDER ALVEOLAR SOFT PART SARCOMA: A CASE REPORT.
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 20, 2022
View publication
Summary: A PRIMARY BLADDER ALVEOLAR SOFT PART SARCOMA: A CASE REPORT.
Tired of the same old research?
Check Latest Advances
Brain Metastasis in Soft Tissue Sarcoma at Initial Presentation.
Journal: Anticancer research
Published: November 04, 2021
View publication
Summary: Brain Metastasis in Soft Tissue Sarcoma at Initial Presentation.
View All Latest Advances